Clinical outcome of subdural versus subgaleal drain after burr-hole drainage for chronic subdural hematoma - Scorecard - MDSpire

Clinical outcome of subdural versus subgaleal drain after burr-hole drainage for chronic subdural hematoma

  • By

  • Sophie H. Carter

  • Maud J. de Rooij

  • Narjes Ahmadian

  • Anouk de Wit

  • Albert van der Zwan

  • Pierre A. J. T. Robe

  • November 1, 2024

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Clinical Outcomes for Subdural and Subgaleal Drains Following Burr-Hole Drainage in Chronic Subdural Hematoma Cases

At a Glance

CategoryDetail
ConditionChronic subdural hematoma (CSDH)
Key MechanismsPathological accumulation of blood between dura mater and arachnoid mater; treated by burr-hole craniostomy with drain placement
Target PopulationAdult patients (>18 years) undergoing burr-hole drainage for de novo CSDH
Care SettingAcademic neurosurgical hospital (Utrecht University Medical Center), perioperative and postoperative neurosurgical care

Key Highlights

  • CSDH incidence increases significantly in elderly, especially >70 years, and with anticoagulant/antithrombotic therapy use.
  • Burr-hole craniostomy with drain placement is gold standard; drain location (subdural vs subgaleal) varies by surgeon preference.
  • Recurrence occurs in 5-30% of cases; drain placement reduces recurrence but subdural drains carry higher risk of complications.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis based on clinical symptoms and CT imaging showing hypodense components of CSDH.
  • Postoperative CT scans are performed only if clinical suspicion of recurrence arises.

Management

  • Standard treatment is burr-hole craniostomy with placement of either subdural or subgaleal drain.
  • Choice of drain location is based on surgeon preference due to lack of evidence-based guidelines.
  • Patients on anticoagulant or antithrombotic therapy managed per institutional protocol around surgery.

Monitoring & Follow-up

  • Follow-up period of six weeks post-surgery with clinical assessment including modified Rankin Scale (mRS).
  • Subsequent follow-up with neurologist at secondary center.
  • Monitoring for neurological symptoms indicative of recurrence or complications.

Risks

  • Subdural drain insertion risks include bleeding, brain injury, convulsions, and infections.
  • Recurrence of CSDH requiring reoperation increases risk of insults and infections.
  • Morbidity and mortality assessed within six weeks postoperatively, including systemic complications.

Patient & Prescribing Data

Adults undergoing burr-hole drainage for de novo chronic subdural hematoma at a tertiary neurosurgical center.

Drain placement reduces recurrence rates; however, subdural drains have higher complication risks compared to subgaleal drains. No standardized guideline dictates drain location, leading to practice variation.

Clinical Best Practices

  • Perform burr-hole craniostomy under general anesthesia unless contraindicated.
  • Use two burr-holes generally unless surgeon deems one sufficient based on hematoma characteristics.
  • Insert drain (subdural or subgaleal) based on surgeon preference, ensuring proper tunneling and anchoring.
  • Manage anticoagulant/antithrombotic therapy according to institutional protocols pre- and postoperatively.
  • Conduct clinical follow-up with mRS assessment and monitor for neurological symptoms to detect recurrence.
  • Reserve postoperative CT imaging for cases with clinical suspicion of recurrence.

References

Original Source(s)

Related Content